Have a feature idea you'd love to see implemented? Let us know!
Back to TGTX overview

TGTX Tg Therapeutics PE ratio, current and historical analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: TGTX
  4. PE Ratio

As of Oct 29, 2024, the Tg Therapeutics stock's price-to-earnings ratio is 37.84. This results from the current EPS of $0.68 and stock price of $25.73.

TGTX PE ratio history

How has TGTX's PE ratio performed in the past
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Tg Therapeutics PE ratio by year

Year PE ratio Change
2023 189.78 N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

TGTX average PE ratio chart

What is the average PE ratio of TGTX for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

TGTX PE vs peers

What is TGTX's PE ratio compared to its peers

TGTX's PE ratio stands higher than its peer stock ALKS.

Stock name PE ratio Market cap
ALKS Alkermes plc 13.22 $4.3B
TGTX Tg Therapeutics Inc 37.19 $3.92B
NERV Minerva Neurosciences Inc N/A $17.79M

Frequently asked questions

What is Tg Therapeutics's PE ratio?

The price to earnings ratio for TGTX stock as of Oct 29, 2024, stands at 37.84.

How is TGTX's PE ratio calculated (Tg Therapeutics PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Oct 29, 2024), Tg Therapeutics's stock price is $25.73. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.68. Therefore, Tg Therapeutics's PE ratio for today is 37.84. PE RATIO(37.84) = STOCK PRICE($25.73) / TTM EPS($0.68)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.